Hydrazine sulfate and preneoplastic exfoliated cells.
Animal experiments and most encouraging clinical trials substantiate that hydrazine sulfate inhibits the paraneoplastic systemic energy-losing cycle. The question arises: could hydrazine sulfate offer an alternative to surgery for patients with preneoplastic exfoliated cells? Research data indicate that clinical trials are appropriate.